Publicaciones en colaboración con investigadores/as de Hospital Arnau de Vilanova (104)

2024

  1. Addressing the unsolved challenges in microRNA-based biomarker development: Suitable endogenous reference microRNAs for SARS-CoV-2 infection severity

    International Journal of Biological Macromolecules, Vol. 269

  2. Decoding viral and host microRNA signatures in airway-derived biosamples: Insights for biomarker discovery in viral respiratory infections

    Biomedicine and Pharmacotherapy, Vol. 177

  3. Impact of OLD/Emphysema in LC Mortality Risk in Screening Programs: An Analysis of NLST and P-IELCAP

    Archivos de Bronconeumologia

  4. MicroRNA-guided drug discovery for mitigating persistent pulmonary complications in critical COVID-19 survivors: A longitudinal pilot study

    British Journal of Pharmacology

  5. Multidisciplinary virtual management of pulmonary nodules

    Pulmonology, Vol. 30, Núm. 3, pp. 239-246

  6. Synergistic impact of N-antigenemia profiled by a rapid antigen test and low anti-S1 antibodies on the risk of hospitalization in COVID-19

    International Journal of Infectious Diseases, Vol. 140, pp. 132-135

2023

  1. A blood microRNA classifier for the prediction of ICU mortality in COVID-19 patients: a multicenter validation study

    Respiratory Research, Vol. 24, Núm. 1

  2. Cellular heterogeneity insights and molecular signatures in paediatric sleep apnoea

    European Respiratory Journal

  3. Cerebrospinal fluid lipidomic fingerprint of obstructive sleep apnoea in Alzheimer's disease

    Alzheimer's research & therapy, Vol. 15, Núm. 1, pp. 134

  4. Circulating miR-133a-3p defines a low-risk subphenotype in patients with heart failure and central sleep apnea: a decision tree machine learning approach

    Journal of Translational Medicine, Vol. 21, Núm. 1

  5. Driving pressure and adjunctive therapies in pulmonary sequelae of COVID-19 patients under invasive ventilation

    Intensive Care Medicine

  6. Effect of viral storm in patients admitted to intensive care units with severe COVID-19 in Spain: a multicentre, prospective, cohort study

    The Lancet Microbe, Vol. 4, Núm. 6, pp. e431-e441

  7. Hour-to-hour variability of respiratory sleep indices and ambulatory blood pressure

    Sleep, Vol. 46, Núm. 2

  8. Hypoxic burden to guide CPAP treatment allocation in patients with obstructive sleep apnoea: a post hoc study of the ISAACC trial

    The European respiratory journal, Vol. 62, Núm. 6

  9. Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients

    Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 205-215

  10. Low adherence to the Mediterranean diet is associated with increased prevalence and number of atherosclerotic plaques in the ILERVAS cohort

    Atherosclerosis, Vol. 380

  11. Metabolipidomic Analysis in Patients with Obstructive Sleep Apnea Discloses a Circulating Metabotype of Non-Dipping Blood Pressure

    Antioxidants, Vol. 12, Núm. 12

  12. Performance of endobronchial ultrasound transbronchial needle aspiration as the first nodal staging procedure for the determination of programmed death ligand-1 expression in non-small cell lung cancer patients

    Journal of Cancer Research and Clinical Oncology, Vol. 149, Núm. 13, pp. 12459-12468

  13. Polysomnographic characterization of circadian blood pressure patterns in patients with obstructive sleep apnea

    Sleep, Vol. 46, Núm. 4

  14. Proteomic profiling for prediction of recurrent cardiovascular event in patients with acute coronary syndrome and obstructive sleep apnea: A post-hoc analysis from the ISAACC study

    Biomedicine and Pharmacotherapy, Vol. 158